Praxis Precision Medicines (PRAX) Change in Accured Expenses (2019 - 2026)

Praxis Precision Medicines' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$17.4 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 109.96% year-over-year to -$17.4 million; the TTM figure through Mar 2026 stood at $2.1 million (down 75.17% YoY), while the FY2025 annual figure was $11.2 million, down 30.48% from the prior year.
• Change in Accured Expenses was -$17.4 million for Q1 2026 at Praxis Precision Medicines, down from $14.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $14.4 million in Q4 2025 to a low of -$17.4 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$531588.2 across 5 years, with a median of $374000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 1491.64% in 2022, then surged 2067.11% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$2.0 million in 2022, then surged by 118.39% to $374000.0 in 2023, then soared by 2067.11% to $8.1 million in 2024, then jumped by 78.01% to $14.4 million in 2025, then sank by 220.49% to -$17.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$17.4 million (Q1 2026), $14.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.